本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibikase Therapeutics, Inc.

1.50
-0.0100-0.66%
成交量:10.13万
成交额:15.32万
市值:1.82亿
市盈率:-2.69
高:1.57
开:1.54
低:1.49
收:1.51
52周最高:4.20
52周最低:1.33
股本:1.21亿
流通股本:7,110.50万
量比:0.29
换手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-0.5579
每股收益(LYR):-1.1606
净资产收益率:-131.71%
总资产收益率:-79.11%
市净率:2.49
市盈率(LYR):-1.29

数据加载中...

2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/17

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/09/20

重要事件披露

Form 8-K - Current report
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/18

重要事件披露

Form 8-K - Current report
2023/06/30

重要事件披露

Form 8-K - Current report